Gerald Marit

Gerald Marit

UNVERIFIED PROFILE

Are you Gerald Marit?   Register this Author

Register author
Gerald Marit

Gerald Marit

Publications by authors named "Gerald Marit"

Are you Gerald Marit?   Register this Author

54Publications

2371Reads

47Profile Views

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Leukemia 2019 Sep 9;33(9):2324-2330. Epub 2019 Apr 9.

ProfilExpert, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0452-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756025PMC
September 2019

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

J Clin Oncol 2017 Oct 25;35(29):3279-3289. Epub 2017 Jul 25.

Philip L. McCarthy, Roswell Park Cancer Institute, Buffalo, NY; Sarah A. Holstein, University of Nebraska Medical Center, Omaha, NE; Maria Teresa Petrucci, University La Sapienza; Antonio Palumbo, Takeda Italia, Rome; Patrizia Tosi, Rimini Hospital, Rimini; Sara Bringhen and Francesca Gay, University of Torino, Torino; Pellegrino Musto, Cancer Institute for Research and Care and The Referral Cancer Center of Basilicata, Rionero in Vulture, Italy; Paul G. Richardson and Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston, MA; Cyrille Hulin and Gerald Marit, Bordeaux Centre Hospitalier Universitaire, Bordeaux; Denis Caillot, Dijon University Hospital Center, Dijon; Philippe Moreau, University Hospital Hôtel-Dieu, Nantes; Michel Attal, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Sin-Ho Jung, Duke University, Durham, NC; and Zhinuan Yu, Benjamin Winograd, and Robert D. Knight, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652871PMC
October 2017

Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

J Clin Oncol 2017 Sep 7;35(25):2911-2918. Epub 2017 Jul 7.

Philippe Moreau, Florence Caillon, Caroline Bodet-Milin, Aurelie Gaultier, Jean-Michel Nguyen, Benoit Dupas, Eric Frampas, and Françoise Kraeber-Bodere, University Hospital, Nantes; Michel Attal, University Hospital, Toulouse; Denis Caillot, University Hospital, Dijon; Margaret Macro, University Hospital, Caen; Lionel Karlin, University Hospital, Lyon; Laurent Garderet, University Hospital Saint-Antoine, Paris; Thierry Facon, University Hospital, Lille; Lotfi Benboubker, University Hospital, Tours; Martine Escoffre-Barbe, University Hospital, Rennes; Anne-Marie Stoppa, Institut Paoli-Calmettes, Marseille; Kamel Laribi, University Hospital, Le Mans; Cyrille Hulin and Gerald Marit, University Hospital, Bordeaux; Aurore Perrot, University Hospital, Nancy; Jean-Richard Eveillard, University Hospital, Brest; Brigitte Pegourie, University Hospital, Grenoble; Veronique Dorvaux, University Hospital, Metz; Carine Chaleteix, University Hospital, Clermont-Ferrand; and Herve Avet-Loiseau, University Hospital, Toulouse, France; and Kenneth Anderson, Paul Richardson, and Nikhil C. Munshi, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2975DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578392PMC
September 2017

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du Myélome.

J Clin Oncol 2014 Sep 14;32(25):2712-7. Epub 2014 Jul 14.

Murielle Roussel, Valérie Lauwers-Cances, Catherine Gentil, Anne Huynh, Benjamin Hebraud, Jill Corre, and Hervé Avet-Loiseau, Hopitaux de Toulouse; Michel Attal, Institut Claudius Regaud, Toulouse; Nelly Robillard, Philippe Moreau, and Soraya Wuilleme, Hôtel Dieu, Nantes; Cyrille Hulin, Centre Hospitalier Brabois, Nancy; Xavier Leleu and Thierry Facon, Hôpital Claude Huriez, Lille; Lotfi Benboubker, Hôpital Bretonneau, Tours; Gérald Marit, Hôpital Haut-Lévêque, Bordeaux Pessac; Brigitte Pegourie, Hôpital Albert Michallon, Grenoble; Denis Caillot and Marie-Lorraine Chretien, Centre Hospitalier Le Bocage, Dijon; Christophe Fruchart, Centre François Baclesse, Caen; and Anne-Marie Stoppa, Institut Paoli Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/10/JCO.2013.54
Web Search
http://200.40.135.66:90/toc/0873/2014/0873-20140901-25-08.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.8164
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.8164DOI Listing
September 2014

Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death.

J Clin Oncol 2014 Jul 2;32(20):2173-80. Epub 2014 Jun 2.

Philippe Moreau, University Hospital Hôtel-Dieu; Jean-Luc Harousseau, Centre Rene Gauducheau, Nantes; Michel Attal, Centre Hospitalier Universitaire (CHU) Toulouse; Hervé Avet-Loiseau, CHU Rangueil, Toulouse; Gerald Marit, University Hospital of Bordeaux, Bordeaux; Cyrille Hulin, CHU Nancy, Nancy; Thierry Facon, Hopital Claude Huriez; Xavier Leleu, University Hospital of Lille, Lille; Denis Caillot, CHU Dijon, Dijon; Lotfi Benboubker, Centre Hospitalier Régional Universitaire Tours, Tours; Jean-Yves Mary, University Hospital Paris Saint-Louis, Paris, France; Michele Cavo, Annalisa Pezzi, and Elena Zamagni, Seràgnoli Institute of Hematology, Bologna; Antonio Palumbo, University of Torino, Torino; Maria Teresa Petrucci, Sapienza University of Rome, Rome; Francesca Patriarca, University Hospital, Udine, Italy; Pieter Sonneveld, Erasmus Medical Center, Rotterdam; Bronno van der Holt, Daniel den Hoed Cancer Center at Erasmus Medical Center, Rotterdam; Henk Lokhorst, University Medical Center Utrecht, Utrecht, the Netherlands; Hartmut Goldschmidt, Universitätsklinikum Heidelberg; Kai Neben, University of Heidelberg, Heidelberg, Germany; Laura Rosinol and Joan Bladé, Hospital Clinic, Barcelona; Juan Jose Lahuerta, Hospital Universitario 12 de Octubre, Madrid; Jesus san Miguel, University of Salamanca; Norma Gutierrez, Hospital Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.0329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879712PMC
July 2014

Occupational exposure to organic solvents and lymphoid neoplasms in men: results of a French case-control study.

Occup Environ Med 2010 Oct;67(10):664-72

Inserm U1018, Centre for Research in Epidemiology and Population Health, 16 av. Paul Vaillant-Couturier, F-94807 Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/oem.2009.049460DOI Listing
October 2010

Prognostic significance of copy-number alterations in multiple myeloma.

J Clin Oncol 2009 Sep 17;27(27):4585-90. Epub 2009 Aug 17.

L'Institut National de la Santé et de la Recherche Médicale U892, Université de Nantes, Institut de Biologie, 9 Quai Moncousu, Nantes, 44093, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.20.6136
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.20.6136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754906PMC
September 2009

Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.

Br J Haematol 2004 Jan;124(2):141-50

Bone Marrow Transplantation Laboratory, Bordeaux 2 University, 146 Rue Léo Saignat, 33076 Bordeaux cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04746.xDOI Listing
January 2004

[Severe hemorrhagic cystitis following allogenic bone marrow transplantation].

Prog Urol 2003 Feb;13(1):131-4

Service d'Urologie, Hôpital Pellegrin, Bordeaux, France.

View Article

Download full-text PDF

Source
February 2003

Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis.

Clin Infect Dis 2003 Jan 6;36(2):229-33. Epub 2003 Jan 6.

Service de Médecine Interne, Hôpital Haut-Lévêque, Centre François Magendie, 33604 Pessac Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/345745DOI Listing
January 2003

Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.

Carcinogenesis 2002 Aug;23(8):1327-33

Bone Marrow Transplantation and Hematology Laboratories, CNRS UMR5540, EA 482 and GESNIT-EA 491, Victor Segalen Bordeaux-2 University, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/23.8.1327DOI Listing
August 2002

[Acute myeloblastic leukemia].

Rev Prat 2002 Feb;52(3):327-31

Service des maladies du sang, centre hospitalier universitaire de Bordeaux, hôpital du Haut-Lévêque, 33604 Pessac.

View Article

Download full-text PDF

Source
February 2002